Angela Botticella

921 total citations
37 papers, 405 citations indexed

About

Angela Botticella is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Angela Botticella has authored 37 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Angela Botticella's work include Lung Cancer Research Studies (16 papers), Lung Cancer Treatments and Mutations (15 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Angela Botticella is often cited by papers focused on Lung Cancer Research Studies (16 papers), Lung Cancer Treatments and Mutations (15 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Angela Botticella collaborates with scholars based in France, United States and Netherlands. Angela Botticella's co-authors include C. Le Péchoux, Benjamin Besse, Laura Mezquita, David Planchard, Antonin Lévy, Lizza Hendriks, Caroline Caramella, Éric Deutsch, Elie Rassy and Joseph Kattan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Angela Botticella

34 papers receiving 401 citations

Peers

Countries citing papers authored by Angela Botticella

Since Specialization

Citations

This map shows the geographic impact of Angela Botticella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Botticella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Botticella more than expected).

Fields of papers citing papers by Angela Botticella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Botticella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Botticella. The network helps show where Angela Botticella may publish in the future.

Co-authorship network of co-authors of Angela Botticella

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Botticella. A scholar is included among the top collaborators of Angela Botticella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Botticella. Angela Botticella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1795P SMARC4, c-MET and PD-L1 expression in pN2 non-small cell lung cancer from LungART IFCT 0503 trial 2025 ·Annals of Oncology ·(unknown), (unknown), C. Le Péchoux, (unknown), (unknown), (unknown), (unknown), Nathalie Cozic, (unknown), Erik Bouvier, Jolyon Dales, (unknown), (unknown), (unknown), Angela Botticella, (unknown), David Planchard, (unknown), (unknown), J. Remon Masip	0
2	Postoperative radiotherapy results in 192 epithelial thymic tumours patients with 10 years of follow-up 2024 ·Radiotherapy and Oncology ·(unknown), (unknown), Angela Botticella, (unknown), (unknown), Benjamin Besse, Élie Fadel, Olaf Mercier, Antonin Lévy, C. Le Péchoux	1
3	Impact of pembrolizumab treatment duration on overall survival and prognostic factors in advanced non-small cell lung cancer: a nationwide retrospective cohort study 2024 ·The Lancet Regional Health - Europe ·(unknown), Stefan Michiels, Noémie Simon‐Tillaux, (unknown), Julia Bonastre, David Planchard, Fabrice Barlési, Jordi Remón, Pernelle Lavaud, Mihaela Aldea, Maxime Frélaut, C. Le Péchoux, Angela Botticella, Antonin Lévy, Anas Gazzah, Stéphanie Foulon, Benjamin Besse	13
4	Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer 2023 ·European Journal of Cancer ·(unknown), Marco Tagliamento, Édouard Auclin, Mihaela Aldea, Maxime Frélaut, Antonin Lévy, José Carlos Benítez, Charles Naltet, Pernelle Lavaud, Angela Botticella, (unknown), Nathalie Chaput, Fabrice Barlési, David Planchard, Benjamin Besse	25
5	1334P Activity of first line immunotherapy or chemo-immunotherapy in advanced NSCLC with SMARCA4 deficiency 2023 ·Annals of Oncology ·(unknown), Maria‐Rosa Ghigna, (unknown), J. Remon Masip, Damien Vasseur, (unknown), Davide Soldato, Pernelle Lavaud, (unknown), (unknown), Maxime Frélaut, (unknown), (unknown), Angela Botticella, Antonin Lévy, J-Y. Scoazec, Fabrice Barlési, David Planchard, Benjamin Besse, Mihaela Aldea	2
6	Combination of radiosurgery and immunotherapy in brain metastases: balance between efficacy and toxicities 2023 ·Current Opinion in Neurology ·Angela Botticella, F. Dhermain	3
7	Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer 2023 ·Clinical and Translational Radiation Oncology ·Antonin Lévy, Jonathan Khalifa, É. Martin, Angela Botticella, (unknown), Pernelle Lavaud, Mihaela Aldea, Benjamin Besse, David Planchard, Fabrice Barlési, Éric Deutsch, Carole Massabeau, J. Doyen, C. Le Péchoux	2
8	Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer 2022 ·Frontiers in Oncology ·(unknown), Laura Mezquita, Siddhartha Devarakonda, Mihaela Aldea, Saiama N. Waqar, (unknown), Jeffrey P. Ward, Angela Botticella, Karen Howarth, (unknown), Clive Morris, Ramaswamy Govindan, Benjamin Besse, Daniel Morgensztern	2
9	Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report 2022 ·Frontiers in Immunology ·Mihaela Aldea, Rakiba Belkhir, Émeline Colomba, Pierre Blanchard, François‐Xavier Danlos, Angela Botticella, (unknown), Éric Deutsch, C. Le Péchoux, David Planchard, Jean‐Marie Michot, Benjamin Besse, Antonin Lévy	0
10	1344P Molecular features of young cannabis smokers with advanced non-small cell lung cancer (aNSCLC) 2021 ·Annals of Oncology ·Mihaela Aldea, Claudia Parisi, (unknown), Luigi Cerbone, Damien Vasseur, Pernelle Lavaud, Charles Naltet, (unknown), Anas Gazzah, Angela Botticella, Antonin Lévy, C. Le Péchoux, Jérôme Le Pavec, Olaf Mercier, Étienne Rouleau, Benjamin Besse, J.C. Soria, Fabrice Barlési, Pauline Pradère, David Planchard	3
11	Thoracic radiotherapy in small cell lung cancer—a narrative review 2021 ·Translational Lung Cancer Research ·Antonin Lévy, Angela Botticella, C. Le Péchoux, Corinne Faivre‐Finn	19
12	RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical Resection 2021 ·Clinical Lung Cancer ·Clémence Basse, Angela Botticella, Thierry Jo Molina, Pierre‐Emmanuel Falcoz, Youssef Oulkhouir, M. Kerjouan, Éric Pichon, Virginie Westeel, Luc Thiberville, Xavier Quantin, Christelle Clément-Duchêne, Jonathan Khalifa, (unknown), (unknown), F. Thillays, Pierre Mordant, Benjamin Besse, P. Thomas, C. Le Péchoux, Nicolas Girard	10
13	Can radiation-recall predict long lasting response to immune checkpoint inhibitors? 2020 ·Radiotherapy and Oncology ·Éric Deutsch, Benjamin Besse, Jérôme Le Pavec, C. Le Péchoux, Angela Botticella, Samy Ammari, Caroline Even, Caroline Robert, Antonin Lévy	10
14	Place de l’immunothérapie dans le cancer bronchique non à petites cellules localement avancé 2020 ·Cancer/Radiothérapie ·Antonin Lévy, J. Doyen, Angela Botticella, (unknown), (unknown), P. Giraud, (unknown), Charles Naltet, Pernelle Lavaud, Benjamin Besse, Pauline Pradère, Olaf Mercier, Caroline Caramella, David Planchard, Éric Deutsch, C. Le Péchoux	3
15	Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors 2019 ·European Journal of Cancer ·Lizza Hendriks, Gerben Bootsma, Jean Mourlanette, Clémence Henon, Laura Mezquita, Roberto Ferrara, Clarisse Audigier-Valette, Julien Mazières, Corentin Lefebvre, Boris Duchemann, Sophie Cousin, C. Le Péchoux, Angela Botticella, Dirk De Ruysscher, Anne‐Marie C. Dingemans, Benjamin Besse	45
16	Cancer du poumon et irradiation ganglionnaire prophylactique : un débat clos ? 2019 ·Cancer/Radiothérapie ·(unknown), Angela Botticella, (unknown), Antonin Lévy, C. Le Péchoux	3
17	P1.01-07 Immune-Related Pneumonitis in NSCLC Patients Treated with Immune Checkpoint Inhibitors (ICI): Impact of Previous Thoracic Radiotherapy 2018 ·Journal of Thoracic Oncology ·Angela Botticella, Toni Ibrahim, Laura Mezquita, Lizza Hendriks, Jérôme Le Pavec, Roberto Ferrara, Caroline Caramella, (unknown), Stéphane Champiat, Jean‐Marie Michot, Pernelle Lavaud, (unknown), (unknown), David Planchard, (unknown), Aurélien Marabelle, (unknown), Benjamin Besse, C. Le Péchoux	4
18	Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment 2018 ·Cancer Treatment Reviews ·Elie Rassy, Angela Botticella, Joseph Kattan, C. Le Péchoux, Benjamin Besse, Lizza Hendriks	53
19	Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer 2018 ·PLoS ONE ·Antoine Schernberg, Laura Mezquita, (unknown), Angela Botticella, Caroline Caramella, Benjamin Besse, Alexandre Escande, David Planchard, C. Le Péchoux, Éric Deutsch	27
20	Optimization of Gross Tumour Volume Definition and Treatment Planning in Lung-Sparing Volumetric Modulated Arc Therapy for Pleural Mesothelioma 2015 ·Annals of Oncology ·Angela Botticella, Gilles Defraene, K. Nackaerts, Christophe M. Deroose, Johan Coolen, Philippe Nafteux, Stéphanie Peeters, Dirk De Ruysscher	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact